-
Founded in:
2004-07-29 -
Country:
China -
Address:
No. 4, Yaogu 1st Road, Haikou National High-tech Industrial Development Zone, Haikou City -
Tax NO.:
914600007603794713 -
Registered Funds:
12.27100815 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sodium Phosphate, Dibasic |
Distends the lower intestine to stimulate the defecation reflex and facilitates stool excretion by increasing the water content of the stool
More
Distends the lower intestine to stimulate the defecation reflex and facilitates stool excretion by increasing the water content of the stool |
7558-79-4 | 19 | |
| Sodium dihydrogen phosphate |
Distends the lower intestine to stimulate the defecation reflex and facilitates stool excretion by increasing the water content of the stool
More
Distends the lower intestine to stimulate the defecation reflex and facilitates stool excretion by increasing the water content of the stool |
89140-32-9 | 9 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Acyclovir |
In vitro, it has an inhibitory effect on herpes simplex virus, varicella zoster virus, cytomegalovirus, etc. The drug is easily taken up by herpes simplex virus, then phosphorylated into triphosphate, which inhibits viral replication in two ways: interfering with viral DNA polymerase and inhibiting viral replication; under the action of DNA polymerase, it binds to the growing DNA chain, causing the extension of the DNA chain to be interrupted.
More
In vitro, it has an inhibitory effect on herpes simplex virus, varicella zoster virus, cytomegalovirus, etc. The drug is easily taken up by herpes simplex virus, then phosphorylated into triphosphate, which inhibits viral replication in two ways: interfering with viral DNA polymerase and inhibiting viral replication; under the action of DNA polymerase, it binds to the growing DNA chain, causing the extension of the DNA chain to be interrupted. |
59277-89-3 | 50 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ozagrel sodium |
This product is a thromboxane synthetase inhibitor that can inhibit the production of TXA2, thus having the effects of anti-platelet aggregation and vasodilation. Animal experiments have shown that intravenous administration can reduce plasma TXB2 levels and the Keto-PGF12/TXB2 ratio, inhibit platelet aggregation caused by different inducers, and prevent cerebral infarction caused by the middle cerebral artery in rats.
More
This product is a thromboxane synthetase inhibitor that can inhibit the production of TXA2, thus having the effects of anti-platelet aggregation and vasodilation. Animal experiments have shown that intravenous administration can reduce plasma TXB2 levels and the Keto-PGF12/TXB2 ratio, inhibit platelet aggregation caused by different inducers, and prevent cerebral infarction caused by the middle cerebral artery in rats. |
189224-26-8 | 10 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ozagrel sodium |
This product is a thromboxane synthetase inhibitor that can inhibit the production of TXA2, thus having the effects of anti-platelet aggregation and vasodilation. Animal experiments have shown that intravenous administration can reduce plasma TXB2 levels and the Keto-PGF12/TXB2 ratio, inhibit platelet aggregation caused by different inducers, and prevent cerebral infarction caused by the middle cerebral artery in rats.
More
This product is a thromboxane synthetase inhibitor that can inhibit the production of TXA2, thus having the effects of anti-platelet aggregation and vasodilation. Animal experiments have shown that intravenous administration can reduce plasma TXB2 levels and the Keto-PGF12/TXB2 ratio, inhibit platelet aggregation caused by different inducers, and prevent cerebral infarction caused by the middle cerebral artery in rats. |
189224-26-8 | 10 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Clindamycin hydrochloride |
|
21462-39-5 | 34 |